Bax, Heather J.
Chauhan, Jitesh
Stavraka, Chara http://orcid.org/0000-0001-7623-299X
Santaolalla, Aida
Osborn, Gabriel
Khiabany, Atousa
Grandits, Melanie
López-Abente, Jacobo
Palhares, Lais C. G. F.
Chan Wah Hak, Charleen
Robinson, Alexandra
Pope, Amy
Woodman, Natalie
Naceur-Lombardelli, Cristina
Malas, Sadek
Coumbe, Jack E. M.
Nakamura, Mano
Laddach, Roman
Mele, Silvia
Crescioli, Silvia
Black, Anna M.
Lombardi, Sara
Canevari, Silvana
Figini, Mariangela
Sayasneh, Ahmad
Tsoka, Sophia http://orcid.org/0000-0001-8403-1282
FitzGerald, Kevin
Gillett, Cheryl
Pinder, Sarah http://orcid.org/0000-0003-4167-8910
Van Hemelrijck, Mieke
Kristeleit, Rebecca http://orcid.org/0000-0003-3825-1326
Ghosh, Sharmistha
Montes, Ana
Spicer, James
Karagiannis, Sophia N. http://orcid.org/0000-0002-4100-7810
Josephs, Debra H. http://orcid.org/0000-0002-5610-9123
Funding for this research was provided by:
Cancer Research UK (C30122/A11527, C30122/A15774, C604/A25135)
Academy of Medical Sciences (N/A)
DH | National Institute for Health Research (CL-2020-17-002)
Breast Cancer Now (147; KCL-BCN-Q3)
Guy’s and St Thomas’ Charity (573)
Article History
Received: 20 July 2021
Revised: 30 September 2022
Accepted: 14 October 2022
First Online: 19 November 2022
Competing interests
: SNK and JS are founders and shareholders of Epsilogen Ltd. KFG is an employee of Epsilogen Ltd. HJB, MG, JL-A and LCGFP are employed through a fund provided by Epsilogen Ltd. SNK, JS, DHJ, HJB and KFG are inventors of patents on antibody technologies. All other authors have declared no conflict of interest.
: Sample collection for this study has been reviewed and approved by the Guy’s Research Ethics Committee (References 09/H0804/45 and 16/LO/0366). Ovarian cancer patients and healthy volunteers were enrolled by written, informed consent.
: Not applicable.